FEDERAL FUNDING

University of Wisconsin System gets $816K more for its Cardiovascular Diseases Research grant

University of Wisconsin System | State of Wisconsin

University of Wisconsin System received $815,985 from the Department of Health and Human Services under Cardiovascular Diseases Research (93.837). This action continues an existing award. Funds can be spent from August 1, 2021 to May 31, 2030.

This action
$815,985
Not the award total
Action date
Sep 4, 2026
69 days ago
Program
Cardiovascular Diseases Research
Assistance listing 93.837
Spending window
3.6 years left
Ends May 31, 2030
$816.0K awardedSep 4

Reach the agencies that just got funded.

Get agency contacts free

Free account · 30-second setup · No credit card

Who to contact

People at University of Wisconsin System | State of Wisconsin, the agency that received this funding.

Award details

Recipient
University of Wisconsin System
Awarding agency
Department of Health and Human Services
Sub-agency
National Institutes of Health
Awarding office
NIH National Heart, Lung, and Blood Institute
Assistance type
Grant
Action
CONTINUATION (modification 001)
Period of performance
August 1, 2021 to May 31, 2030
Award ID (FAIN)
R01HL157262

About this award

From the award's filing with the federal government.

Developing a clinical decision support tool for the identification, diagnosis, and treatment of critical illness in hospitalized patients - project summary up to 5% of hospitalized adult patients on the medical-surgical wards develop clinical deterioration requiring intensive care. Medical errors are common before deterioration events, including delays and misjudgments in identification, diagnosis, and treatment, and these errors lead to increased morbidity and mortality. Therefore, it is critically important to improve the care of high-risk ward patients to decrease preventable in-hospital deaths. The current paradigm for attempting to decrease mortality from deterioration has several limitations. First, most early warning scores designed to identify high-risk patients are based only on vital signs and have limited accuracy. Clinical notes are an underutilized, rich source of information comprising nearly 80% of electronic health record (ehr) data. Natural language processing (nlp) can extract important risk factors from clinical notes for machine learning models to improve accuracy over existing tools. Second, current early warning scores only tell clinicians that a patient is at high risk but provide no information regarding what clinical condition is causing a patient’s deterioration. This leads to diagnostic and treatment errors, which results in worse patient outcomes. Developing tools to enhance diagnostic accuracy for high-risk ward patients could lead to fewer medical errors, decreased costs, and improved outcomes. Third, the initial treatment decisions for deteriorating patients are made by clinicians with limited experience caring for critically ill patients, which can result in delays of potentially life-saving therapies. By utilizing a large, granular, multicenter dataset, algorithms to predict the treatments a patient should receive can be developed, resulting in early, targeted, potentially life-saving therapy. The long-term goal is to develop and implement clinically useful decision support tools to decrease preventable death from deterioration. The overall objective of this project is to develop a clinical decision support tool for the identification, diagnosis, and treatment of patients at high risk of deterioration. This objective will be pursued in the following three specific aims: 1) develop machine learning models to identify patients at high risk of deterioration using both structured data and unstructured clinical notes; 2) develop models to predict the diagnosis that is causing the deterioration event and the potentially life-saving treatments that should be provided to high-risk patients; 3) develop a clinical decision support tool with a graphical user interface incorporating the models from aims 1 and 2 via user-centered design principles and then test its effectiveness, efficiency, and user satisfaction in a case-based simulation study. This research is innovative because it will utilize nlp, reinforcement learning, interpretable machine learning, and multi-task transfer learning approaches. The proposed research is significant because it will provide clinicians with powerful new tools that can be implemented in the ehr to identify, diagnose, and make treatment recommendations for high-risk patients. This will result in the delivery of early, personalized care to decrease preventable death from deterioration.

From USAspending

This record comes from USAspending.gov, the federal government's public database of spending. It describes one action on the award, so the amount shown is not the award's total.

View this award on USAspending(opens in a new tab)

Transaction 7529_R01HL157262_R01HL157262-1815123988_93.837_001

Work in government? Get Civic IQ free →

Start finding government buyers today.
It's free.

B2G and SLED sales intelligence. Surface government procurement signals from 100,000+ state, local, and education agencies months before the RFP.

Get started free

No credit card required